Grants for Native American tribal organizations - Health

This funding opportunity provides financial support to organizations that help young adults aged 16-25 with serious emotional or mental health challenges access culturally and developmentally appropriate services as they transition into adulthood.

This grant provides financial support and mentorship for early-career clinician-scientists to develop their research skills in pain management, focusing on innovative approaches to understanding and treating pain without leading clinical trials.

This funding opportunity supports early-stage researchers and those new to Alzheimer's Disease and related dementias research, providing resources to develop innovative pilot projects aimed at improving prevention, diagnosis, treatment, and care strategies.

This funding opportunity supports diverse institutions and researchers in conducting innovative research to promote health equity and improve health outcomes for all individuals, particularly by addressing social determinants of health and eliminating health disparities.

This program provides funding to local organizations in EPA Region 3 for projects that address environmental and health challenges in historically underserved communities.

Reissue of RFA-MH-22-115 to comply with DMSP policy. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits and provide insights into cellular interactions that underlie brain function. Critical advances in the treatment of brain disorders in human populations are hindered by our lack of ability to monitor and manipulate circuitry in safe, minimally-invasive ways. Clinical intervention with novel cell and circuit specific tools will require extensive focused research designed to remove barriers to delivery of gene therapies. In addition to identification and removal of barriers, the need to specifically target dysfunctional circuitry poses additional challenges. Neuroscience has experienced an impressive influx of exciting new research tools in the past decade, especially since the launch of the BRAIN Initiative. However, the majority of these cutting edge tools have been developed for use in model organisms, primarily rodents, fish and flies. These cutting edge tools, such as viral delivery of genetic constructs, are increasingly adaptable to large brains and more importantly are emerging as potential human therapeutic strategies for brain disorders. A pressing need to develop tools for use in large brains, more directly relevant to the human brain is the focus of this initiative. The new tools and technologies should inform and/or exploit cell-type and/or circuit-level specificity. Plans for validating the utility of the tool/technology will be an essential feature of a successful application.

This funding opportunity supports researchers in planning high-risk, multi-center clinical studies focused on kidney, digestive, diabetes, and metabolic disorders, helping them develop essential protocols and administrative frameworks before conducting the actual trials.

This funding opportunity supports research to improve cancer care and outcomes for sexual and gender minority survivors by addressing their unique challenges and engaging community partners in the process.

This grant provides funding for researchers to evaluate community and societal programs aimed at preventing adverse childhood experiences and addressing social and health inequities.

This grant provides funding to support postdoctoral researchers from underrepresented backgrounds in transitioning to independent cancer research roles, with a focus on clinical trials and addressing cancer health disparities.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

This grant provides funding to institutions and organizations for establishing a centralized data coordination center that will manage and share research data on how socioenvironmental factors influence neurocognitive development and addiction risk.

This funding opportunity supports multi-site clinical trials for innovative treatments and interventions aimed at preventing or alleviating symptoms of Alzheimer's disease and related dementias, inviting applications from a diverse range of organizations and institutions.

This funding opportunity supports innovative research projects aimed at developing tools and treatments for diagnosing and mitigating injuries from radiation exposure during public health emergencies.

This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC will be considered not acceptable to this FOA.

The Colorado Department of Public Health and Environment's (CPDHE) Office of Gun Violence Prevention (OGVP) has established a grant program to support community-based initiatives aimed at interrupting cycles of gun violence, trauma, and retaliation. This program aligns with the OGVP's mission to address disparities in communities at the highest risk by focusing on firearm suicide prevention and community violence intervention. The program targets communities and individuals most impacted by firearm homicides and suicides, including Black, Latino, Indigenous, and other People of Color communities; LGBTQIA+ communities; youth and young adults; veterans; middle-aged men; and isolated rural communities. The overarching impact goal is to reduce firearm-related harm and death, fostering safer and more resilient communities. The grant funding is structured around two primary paths. Path 1 focuses on the prevention of unintentional and intentional firearm-related harm through strategies like promoting safe storage, lethal means counseling, and educating the public on Extreme Risk Protection Orders. Path 2 is dedicated to Community Violence Intervention or Interruption, utilizing strategies such as Hospital-Based Violence Intervention Programs (HVIPs), Community-Based Intervention Programs (CVIPs) with "credible messenger" models, and Violence Interruption Programs that provide immediate responses to shootings and promote non-violence. Expected outcomes include a reduction in unauthorized firearm access, increased education on temporary out-of-home gun storage, decreased firearm suicides, and a decrease in community violence through intervention and interruption strategies. Measurable results will likely involve tracking participation in safe storage programs, knowledge of ERPOs, engagement in violence intervention programs, and ultimately, a reduction in firearm-related incidents and deaths in targeted communities. The OGVP's strategic priority is to address disparities in high-risk communities, and its theory of change posits that by investing in community-led initiatives focused on prevention and intervention, it can effectively break cycles of violence and trauma. Total available funding is approximately $500,000 each fiscal year, with up to 10 grant awards ranging from $50,000 to $100,000 per awardee. The initial funding period runs from July 1, 2024, to June 30, 2026, with a potential for renewal through 2027. Eligible applicants include Colorado-based community and grassroots nonprofit organizations, nonprofit educational institutions, nonprofit healthcare organizations, and nonprofit organizations serving reservations or Tribal land. The program particularly encourages applications from organizations advocating for or serving the identified priority communities.

This funding opportunity supports early-career clinical researchers in the U.S. to develop expertise in implementation science for substance use prevention and treatment through mentored clinical trials addressing the overdose crisis.

The "Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD)" grant aims to fund the creation and testing of new, complex human cell models that accurately represent Alzheimer's and related dementias, with the goal of improving our understanding of these diseases and aiding in the development of potential therapies.

This grant provides funding for educational programs that improve the skills and knowledge of researchers analyzing large, complex datasets related to brain function, behavior, and social factors affecting health outcomes.

The purpose of the program is to provide resources to graduate-level students in medical (MD/DO), physician assistant (PA), nurse practitioner (NP) and other eligible nursing programs (clinical nurse specialists (CNS), certified registered nurse anesthetists (CRNA), certified nurse midwives (CNM) practices) receive the theoretical knowledge and practical training required for them to treat opioid use disorders (OUD) and prescribe medications for opioid use disorder (MOUD) in office-based settings upon graduation and receipt of licensure.